News
Pfizer gets US FDA approval for PANZYGA to treat chronic inflammatory demyelinating polyneuropathy
Pfizer announced that the US FDA has approved the supplemental Biologics License Application (sBLA) for PANZYGA (Immune Globulin Intravenous – ifas 10% Liquid...
News
Pfizer and BioNTech to Supply the United States with 100 Million Additional Doses of COVID-19 Vaccine
Pfizer Inc. and BioNTech SE announced that the U.S. government has exercised its option for an additional 100 million doses of the Pfizer-BioNTech COVID-19...
News
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease
Exscientia, a leading AI Drug Discovery company, has today announced its collaboration with the Alzheimer’s Research UK University of Oxford Drug Discovery Institute (ARUK-ODDI)...
Drug Research
AstraZeneca, IDT To Ramp Up COVID-19 Vaccine Manufacturing In Europe
Following the European Medicines Agency (EMA) approval, millions of AstraZeneca vaccines began shipping on 5 February as part of the initial 17m doses that...
News
Qatar approves emergency use of Modernas COVID-19 vaccine
Qatari authorities have issued an emergency use authorisation for Moderna’s COVID-19 vaccine, the second coronavirus jab approved in the country after the one developed...
News
Evonik strengthens strategic partnership with BioNTech on COVID-19 vaccine
Evonik is investing in the short-term expansion of its specialty lipids production which are essential for mRNA-based COVID-19 vaccines. Commercial lipid quantities are to...
News
Novartis buys antibiotics business from GSK in generics push
GSK has announced it has reached an agreement with Sandoz, a Novartis division, to sell its Cephalosporin antibiotics business. Sandoz will pay GSK USD...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read